| HCV | hepatitis C virus |
| DAA | direct-acting antiviral |
| SVR | sustained virological response |
| LDL-C | low-density lipoprotein cholesterol |
| HDL-C | high-density lipoprotein cholesterol |
| BMI | body mass index |
| APRI | aspartate aminotransferase-to-platelet ratio index |
| FIB-4 | fibrosis-4 index |
| CI | confidence interval |
| GLE/PIB | glecaprevir/pibrentasvir |
| LDV/SOF | ledipasvir/sofosbuvir |
| OMB/PAR/RIT + DAS | ombitasvir/paritaprevir/ritonavir + dasabuvir |
| SOF/VEL | sofosbuvir/velpatasvir |
| HCC | hepatocellular carcinoma |